Today: 3 May 2026
Browse Category

NASDAQ:CORT.O 1 January 2026

Corcept Therapeutics stock tanks on FDA relacorilant setback — what happens next for CORT

Corcept Therapeutics stock tanks on FDA relacorilant setback — what happens next for CORT

Corcept Therapeutics shares plunged 50.4% to $34.80 on Dec. 31 after the FDA declined to approve relacorilant for hypercortisolism-related hypertension, citing insufficient evidence of effectiveness. Wolfe Research downgraded the stock to Underperform with a $30 target. Trading was briefly halted before resuming with heavy volume. The FDA set a separate July 2026 decision date for relacorilant in ovarian cancer.
1 January 2026
··

Stock Market Today

  • Is XPeng (XPEV) Share Price Overvalued After Recent Declines?
    May 2, 2026, 11:10 PM EDT. XPeng's stock price closed at $15.83, falling 5% in the last week and 19.9% over the past year, despite a 52.2% gain over three years. A Discounted Cash Flow (DCF) analysis estimates XPeng's intrinsic value at $7.63 per share, suggesting the stock may be overvalued by 107.6% relative to current prices. The company's Price to Sales (P/S) ratio stands at 1.35, reflecting mixed signals amid volatile earnings and growth outlook. With a valuation score of 2 out of 6, XPeng shows signs of being undervalued on some metrics but overvalued on others, leaving investors weighing whether sentiment or fundamentals are driving the market price.

Latest article

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

3 May 2026
Vertiv shares hit a 52-week high Friday before closing at $328.31, following a 30% jump in Q1 net sales to $2.65 billion. The company raised its 2026 outlook and recently acquired Strategic Thermal Labs, expanding its liquid cooling portfolio. Investors await further details at Vertiv’s May 19-20 conference in South Carolina.
AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

3 May 2026
AT&T closed a $6 billion sale of long-dated notes on April 30, with maturities ranging from 2033 to 2066, according to an SEC filing. The company reported first-quarter free cash flow of $2.5 billion, down from $3.1 billion a year earlier, citing higher capital investment. AT&T is preparing to close a $23 billion purchase of EchoStar spectrum licenses. CFO Pascal Desroches said net debt to adjusted EBITDA rose to 2.71 times.
JPMorgan Chase’s New Filing Shows the $31.4 Billion Number Investors Are Watching

JPMorgan Chase’s New Filing Shows the $31.4 Billion Number Investors Are Watching

3 May 2026
JPMorgan Chase reported first-quarter net income of $16.5 billion, up 13% from a year earlier, with revenue rising 10% to $49.8 billion. The bank’s SEC filing showed a $31.4 billion credit-loss allowance and noninterest expense up 14% to $26.9 billion. Nonperforming assets rose 10% to $10 billion. Shares closed Friday at $312.47, valuing the bank at about $864.8 billion.
Go toTop